期刊
JOURNAL OF IMMUNOLOGY
卷 187, 期 1, 页码 490-500出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1100123
关键词
-
类别
资金
- Babcock Research Endowment
- Dermatology Foundation
- National Psoriasis Foundation
- Training Grant in Cell and Molecular Dermatology [5T32AR007197-33]
- Public Health Service [5R01HL088419]
IL-17 and IL-23 are known to be absolutely central to psoriasis pathogenesis because drugs targeting either cytokine are highly effective treatments for this disease. The efficacy of these drugs has been attributed to blocking the function of IL-17-producing T cells and their IL-23-induced expansion. However, we demonstrate that mast cells and neutrophils, not T cells, are the predominant cell types that contain IL-17 in human skin. IL-17(+) mast cells and neutrophils are found at higher densities than IL-17(+) T cells in psoriasis lesions and frequently release IL-17 in the process of forming specialized structures called extracellular traps. Furthermore, we find that IL-23 and IL-1 beta can induce mast cell extracellular trap formation and degranulation of human mast cells. Release of IL-17 from innate immune cells may be central to the pathogenesis of psoriasis, representing a fundamental mechanism by which the IL-23-IL-17 axis mediates host defense and autoimmunity. The Journal of Immunology, 2011, 187: 490-500.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据